The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry.
The largest deal of the week is Illumina, Inc.‘s acquisition of GRAIL for $8 billion. GRAIL was founded by Illumina in 2016 and was spun out as a standalone company raising $2 billion. The company uses Illumina’s NGS technology to develop data science and machine learning and create the atlas of cancer signals in the blood, enabling multi-cancer early detection tests. Illumina stockholders are expected to own approximately 93% of the combined company, while GRAIL stockholders are expected to own approximately 7%.
To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for the serious analyst and investor. Every day, this service alerts you to developments in all the key segments of the health care service and technology markets.
Biotechnology | ||
Acquirer | Target | Price |
Illumina, Inc. | GRAIL | $8,000,000,000 |
Roche | Inflazome | $447,531,700 |
eHealth | ||
Acquirer | Target | Price |
Halo Labs Inc. | Cannafeels | $4,880,872 |
Hospitals | ||
Acquirer | Target | Price |
UMass Memorial Health Care | Harrington HealthCare System | N/A |
Laboratories, MRI and Dialysis | ||
Acquirer | Target | Price |
Ampersand Capital Partners | GeneWerk GmbH | N/A |
Ampersand Capital Partners | American Laboratory Products Company, Ltd. | N/A |
Long-Term Care | ||
Acquirer | Target | Price |
Atlas Senior Living | 3 assisted living communities | N/A |
Avanath Capital Management | Cascades Village Senior Apartments | $27,150,000 |
Owner/operator | Sterling Meadows | $2,850,000 |
Pharmaceuticals | ||
Acquirer | Target | Price |
Permira | Neuraxpharm Arzneimittel GmbH | $1,880,000,000 |
Other Services | ||
Acquirer | Target | Price |
Aoyuan Healthy Life Group Company Limited | Zhejiang Liantianmei Corporate Management Company Limited | $101,961,009 |
Thomas H. Lee Partners and Frazier Healthcare Partners | Adare Pharmaceuticals | N/A |
Odyssey Investment Partners, LLC | ProPharma Group | N/A |
KKR & Co. L.P. | 1-800-CONTACTS, Inc. | N/A |
W20 | Elysia Group | N/A |